首页> 外文期刊>European journal of ophthalmology >Clinical outcome and subjective quality of life after photodynamic therapy in patients with age-related macular degeneration.
【24h】

Clinical outcome and subjective quality of life after photodynamic therapy in patients with age-related macular degeneration.

机译:年龄相关性黄斑变性患者光动力治疗后的临床结局和主观生活质量。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Whereas the efficacy of photodynamic therapy (PDT) in preventing the progression of age-related macular degeneration (ARMD) is established, its effect on quality of life is under discussion. METHODS: All patients who underwent PDT during 2000 and 2001 at the University Eye Hospital of Mainz were interviewed using a standardized 82-item questionnaire on quality of life and patient satisfaction in ophthalmologic patients. Information was assessed in terms of 82 questions; global scores ranging from 1.0 (optimum self-estimated quality of life) to 4.0 (worst) were derived. Cataract patients' scores were used to characterize the ARMD patients' subjective outcome; the latter were then related to clinical outcome parameters via logistic regressions. RESULTS: A total of 84 patients (50% female, median age 77 years) were interviewed, who underwent a median of three PDT interventions. During the period of PDT treatment, their median decrease in visual acuity was 3 lines from 0.125 to 0.063. Patients whoreported a subjective increase in visual function during this period showed a median private flexibility score of 1.86; patients with the subjective impression of visual function decrease, a median score of 2.71; the median scores for mobility were 2.00 versus 3.00, for flexibility in reading 1.91 versus 3.64, for psychological stress 1.56 versus 2.25, and for communicational flexibility 1.72 versus 2.25. The difference in reading flexibility was statistically significant (p=0.001) after correction for clinical cofactors. CONCLUSIONS: The established clinical benefit of PDT treatment concerning its efficacy in ARMD progression prevention coincides with an at least slight subjective benefit in quality of life and patient satisfaction. However, the latter is associated with the patients' subjective impression of visual acuity progression rather than with clinically validated outcome after PDT treatment.
机译:目的:尽管建立了光动力疗法(PDT)预防与年龄有关的黄斑变性(ARMD)进展的功效,但其对生活质量的影响正在讨论中。方法:对美因茨大学眼科医院在2000年至2001年接受PDT治疗的所有患者,使用标准化的82项问卷调查了有关眼科患者的生活质量和患者满意度,并进行了访谈。根据82个问题对信息进行了评估;得出从1.0(最佳自我评估的生活质量)到4.0(最差)的整体评分。白内障患者评分用于描述ARMD患者的主观结果。然后通过逻辑回归将后者与临床结果参数相关。结果:总共采访了84名患者(女性占50%,中位年龄77岁),他们接受了三种PDT干预措施的中位数。在PDT治疗期间,他们的视力中位数下降是3系,从0.125到0.063。报告在此期间主观视觉功能增加的患者显示中位私人灵活性得分为1.86;视觉功能的主观印象下降的患者,中位数为2.71;流动性的中位数分别是2.00和3.00,阅读的灵活性分别是1.91和3.64,心理压力的得分分别为1.56和2.25,以及沟通的灵活性为1.72和2.25。校正临床辅助因子后,阅读灵活性的差异具有统计学意义(p = 0.001)。结论:关于PDT预防ARMD进展的功效,PDT治疗已确立的临床益处与生活质量和患者满意度方面的至少主观益处相吻合。然而,后者与患者对视力进展的主观印象有关,而不与PDT治疗后的临床验证结果有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号